Drug Shortage Report for PROCTOSEDYL
| Report ID | 5285 |
| Drug Identification Number | 02223260 |
| Brand name | PROCTOSEDYL SUPPOSITORIES |
| Common or Proper name | PrPROCTOSEDYL® 0.5% Suppositories |
| Company Name | APTALIS PHARMA CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN |
| Strength(s) | 5MG 5MG 10MG 10MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL |
| Packaging size | 12 and 24 suppositories |
| ATC code | C05AA |
| ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2013-03-01 |
| Estimated end date | Unknown |
| Actual end date | 2017-04-05 |
| Shortage status | Resolved |
| Updated date | 2019-03-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-03-05 | French | Compare |
| v4 | 2019-03-05 | English | Compare |
| v3 | 2017-04-04 | French | Compare |
| v2 | 2017-04-04 | English | Compare |
| v1 | 2017-04-04 | English | Compare |
Showing 1 to 5 of 5